University of Cincinnati - Department of Internal Medicine Pulmonary, Critical Care & Sleep Medicine Trials

University of Cincinnati - Department of Internal Medicine Pulmonary, Critical Care & Sleep Medicine	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Elwing, Jean M

ARTISAN, NCT05203510: A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension

Recruiting

Parenteral Treprostinil, Remodulin, Oral Treprostinil, Orenitram

United Therapeutics, Lung Biotechnology PBC

Pulmonary Arterial Hypertension

12/25

12/27

NCT03626688 / 2018-001187-33: A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Recruiting

1000

Europe, Canada, US, RoW

Ralinepag, APD811, Placebo

United Therapeutics

PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, Vascular Diseases, Cardiovascular Diseases, Hypertension, Pulmonary, Lung Diseases, Respiratory Tract Disease

12/25

IMPAHCT, NCT05036135 / 2021-001910-13: A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)

Terminated

2/3

202

Europe, Canada, US, RoW

AV-101, Placebo

Aerovate Therapeutics, Aerovate Therapeutics, Inc.

Pulmonary Arterial Hypertension

08/24

ELEVATE 2, NCT04712669 / 2020-004971-42: A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension

Completed

108

Europe, Canada, US, RoW

rodatristat ethyl 300 mg tablet BID, rodatristat ethyl 600 mg BID, Placebo

Altavant Sciences GmbH

Pulmonary Arterial Hypertension

06/23

08/23



	Diseases Companies Products Productz Mechanisms of Action Sites